Natera (NTRA) Prices 4.166M Share Class A Follow-On Offering at $60/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Natera Announces Pricing of Follow-On Offering
September 11, 2020 12:53 AM EDTSAN CARLOS, Calif., Sept. 10, 2020 /PRNewswire/ --Â Natera, Inc. (Nasdaq:Â NTRA), a global leader in cell-free DNA testing, today announced the pricing of its underwritten public offering of 4,166,666 shares of its common stock at a price to the public of $60.00 per share. Closing of the offering is expected to occur on September 15, 2020, subject to customary closing conditions. In addition, Natera has granted the underwriters a 30-day option to purchase up to an additional 624,999 shares of its common stock from Natera at the public offering price less the underwriting... More
